Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Rabindran, Sridhar"'
Autor:
Kwak, Eunice L., Sordella, Raffaella, Bell, Daphne W., Godin-Heymann, Nadia, Okimoto, Ross A., Brannigan, Brian W., Harris, Patricia L., Driscoll, David R., Fidias, Panos, Lynch, Thomas J., Rabindran, Sridhar K., McGinnis, John P., Wissner, Allan, Sharma, Sreenath V., Isselbacher, Kurt J., Settleman, Jeffrey, Haber, Daniel A.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2005 May . 102(21), 7665-7670.
Externí odkaz:
https://www.jstor.org/stable/3375592
Autor:
Ji, Hongbin, Zhao, Xiaojun, Yuza, Yuki, Shimamura, Takeshi, Li, Danan, Protopopov, Alexei, Jung, Boonim L., McNamara, Kate, Xia, Huili, Glatt, Karen A., Thomas, Roman K., Sasaki, Hidefumi, Horner, James W., Eck, Michael, Mitchell, Albert, Sun, Yangping, Al-Hashem, Ruqayyah, Bronson, Roderick T., Rabindran, Sridhar K., Discafani, Carolyn M., Maher, Elizabeth, Shapiro, Geoffrey I., Meyerson, Matthew, Wong, Kwok-Kin
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2006 May . 103(20), 7817-7822.
Externí odkaz:
https://www.jstor.org/stable/30049340
Autor:
Wang, Yanong D. a, ⁎, Honores, Erick a, Wu, Biqi a, Johnson, Steve a, Powell, Dennis a, Miranda, Miriam b, McGinnis, John P. b, Discafani, Carolyn b, Rabindran, Sridhar K. b, Cheng, Wendy a, Krishnamurthy, Girija a
Publikováno v:
In Bioorganic & Medicinal Chemistry 2009 17(5):2091-2100
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1991 May . 88(10), 4109-4113.
Externí odkaz:
https://www.jstor.org/stable/2356992
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1991 Aug . 88(16), 6906-6910.
Externí odkaz:
https://www.jstor.org/stable/2357590
Publikováno v:
Science, 1993 Jan 01. 259(5092), 230-234.
Externí odkaz:
https://www.jstor.org/stable/2880574
Autor:
Rabindran, Sridhar K. *
Publikováno v:
In Cancer Letters 2005 227(1):9-23
Autor:
Hellmann, Matthew, Paz-Ares, Luis, Bernabe Caro, Reyes, Zurawski, Bogdan, Kim, Sang-We, Carcereny Costa, Enric, Park, Keunchil, Alexandru, Aurelia, Lupinacci, Lorena, de La Mora Jimenez, Emmanuel, Sakai, Hiroshi, Albert, Istvan, Vergnenègre, Alain, Peters, Solange, Syrigos, Konstantinos, Barlesi, Fabrice, Reck, Martin, Borghaei, Hossein, Brahmer, Julie, O'Byrne, Kenneth, Geese, William, Bhagavatheeswaran, Prabhu, Rabindran, Sridhar, Kasinathan, Ravi, Nathan, Faith, Ramalingam, Suresh, O’byrne, Kenneth
Publikováno v:
New England Journal of Medicine
r-IGTP: Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
New England Journal of Medicine, 2019, 381 (21), pp.2020-2031. ⟨10.1056/NEJMoa1910231⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
New England Journal of Medicine, Massachusetts Medical Society, 2019, 381 (21), pp.2020-2031. ⟨10.1056/NEJMoa1910231⟩
r-IGTP: Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
New England Journal of Medicine, 2019, 381 (21), pp.2020-2031. ⟨10.1056/NEJMoa1910231⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
New England Journal of Medicine, Massachusetts Medical Society, 2019, 381 (21), pp.2020-2031. ⟨10.1056/NEJMoa1910231⟩
[Background] In an early-phase study involving patients with advanced non–small-cell lung cancer (NSCLC), the response rate was better with nivolumab plus ipilimumab than with nivolumab monotherapy, particularly among patients with tumors that expr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18ad09d5c956f063b752bce70429dbbb
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1330
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1330
BACKGROUND: In an early-phase study involving patients with advanced non-small-cell lung cancer (NSCLC), the response rate was better with nivolumab plus ipilimumab than with nivolumab monotherapy, particularly among patients with tumors that express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::74ed3bef0b44a486d00406d868cbbb3f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3206042
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3206042
Autor:
Hoang, Arthur T. *, Huang, Jiapeng †, Rudra-Ganguly, Nandini *, Zheng, Jianping *, Powell, William C. *, Rabindran, Sridhar K. ‡, Wu, Carl §, Roy-Burman, Pradip *, †, *
Publikováno v:
In The American Journal of Pathology 2000 156(3):857-864